Location History:
- Portolla Valley, CA (US) (2002)
- Portola Valley, CA (US) (1994 - 2019)
Company Filing History:
13 out of 5,309 
5 out of 8 
1 out of 25 
Years Active: 1994-2019
Title: **Eugene C. Butcher: A Trailblazer in Innovative Medical Solutions**
Introduction
Eugene C. Butcher, based in Portola Valley, California, is a prolific inventor with an impressive portfolio of 26 patents. His work focuses primarily on the treatment of autoimmune diseases, utilizing cutting-edge methodologies that pave the way for advancements in biomedical research and therapeutics.
Latest Patents
Among his notable contributions, Eugene's latest patents include "DGAT1 Inhibition for Treatment of Demyelinating Inflammatory Disease," which outlines methods to treat autoimmune diseases by inhibiting the activity of DGAT1. This innovative approach offers a new avenue for tackling demyelinating conditions. Another significant patent is "Function Homology Screening," which provides a method to screen biologically active agents through the analysis of complex biological responses in cell cultures. This patent also details the identification of cell selection methods and optimized culture conditions, allowing for the rapid identification and characterization of potential drug candidates and genetic pathways.
Career Highlights
Eugene has had a distinguished career, working at reputable institutions like Leland Stanford Junior University. His extensive research background has significantly contributed to the fields of immunology and cellular biology, laying the groundwork for further innovations in treating complex diseases.
Collaborations
Throughout his career, Eugene has collaborated with esteemed colleagues, including Ellen L. Berg and Jennifer Melrose. These partnerships have fostered a collaborative environment that has been instrumental in the advancement of his research and the successful development of his patents.
Conclusion
Eugene C. Butcher stands out as a leading inventor whose contributions have a profound impact on medical research and treatments. His dedication to innovation continues to inspire progress in the scientific community, benefiting patients and advancing our understanding of autoimmune disorders.